Ploidy Analysis and Ki-67 Expression in Myelodysplastic Syndromes

References

• Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C. (1982). Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol., 51, 189–199.
   PubMed Web of Science ®Google Scholar
• Foucar, K., Langdon, R. M., Armitage, J. O., Olson, D. B. and Carroll, T. J., Jr. (1985). Myelodysplastic syndromes: A clinical and pathologic analysis of 109 cases. Cancer, 56, 553–561.
   PubMed Web of Science ®Google Scholar
• Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. and Bennett, J. (1997). International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079–2088.
   PubMed Web of Science ®Google Scholar
• Wu, H. K., Kitamura, K., Xi, Y. R., Wang, Y. T., Liu, S. L. and Zhou, D. B. (1992). Cytogenetic analysis of bone marrow from patients with primary myelodysplastic syndrome. J. Int. Med. Res., 20, 254–266.
   PubMed Web of Science ®Google Scholar
• Nowell, P. C. (1992). Chromosome Abnormalities in Myelodysplastic Syndromes. Semin. Oncol., 19, 25–33.
   PubMed Web of Science ®Google Scholar
• Clark, R., Peters, S., Hoy, T., Smith, S., Whittaker, K. and Jacobs, A. (1986). Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes. N. Engl. J. Med., 314, 1472–1475.
   PubMed Web of Science ®Google Scholar
• Osborne, B. M., Uthman, M. O., Butler, J. J. and McLaughlin, P. (1990). Differentiation of T-cell lymphoma from Hodgkin's disease: Mitotic rate and S-phase analysis. Am. J. Clin. Pathol., 93, 227–232.
   PubMed Web of Science ®Google Scholar
• Joensuu, H., Klemi, P. J. and Korkeila, E. (1988). Prognostic value of DNA ploidy and proliferative activity in Hodgkin's disease. Am. J. Clin. Pathol., 90, 670–673.
   PubMed Web of Science ®Google Scholar
• Bettencourt, M. C., Bauer, J. J., Sesterhenn, I. A., Mostofi, F. K., McLeod, D. G. and Moul, J. W. (1996). Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. J. Urol., 156, 1064–1068.
   PubMed Web of Science ®Google Scholar
• Karlsson, M., Boeryd, B., Carstensen, J., Franlund, B., Gustafsson, B., Kagedal, B., Sun, X. F. and Wingren, S. (1996). Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Eur. J. Cancer [A], 32A, 357–362.
   PubMed Web of Science ®Google Scholar
• Bohm, J., Koch, S., Gais, P., Jutting, U., Prauer, H. W. and Hofler, H. (1996). Prognostic value of MIB-1 in neuroendocrine tumours of the lung. J. Pathol., 178, 402–409.
   PubMed Web of Science ®Google Scholar
• Ben-Ezra, J. M., King, B. E., Harris, A. C., Todd, W. M. and Kornstein, M. J. (1994). Staining for bcl-2 protein helps to distinguish benign from malignant lymphoid aggregates in bone marrow biopsies. Mod. Pathol., 7, 560–564.
   PubMed Web of Science ®Google Scholar
• Varela, B. L., Chuang, C., Woll, J. E. and Bennett, J. M. (1985). Modifications in the classification of primary myelodysplastic syndromes: The addition of a scoring system. Hematol. Oncol., 3, 55–63.
   PubMed Web of Science ®Google Scholar
• Raza, A., Gezer, S., Mundle, S., Gao, X. V., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V. and Parcharidou, A. (1995). Apoptosis in bone marrow samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268–276.
   PubMed Web of Science ®Google Scholar
• Jensen, I. M. and Hokland, P. (1994). The proliferative activity of myelopoiesis in myelodysplasia evaluated by multiparameter flow cytometry. Br. J. Haematol., 87, 477–482.
   PubMed Web of Science ®Google Scholar
• Peters, S. W., Clark, R. E., Hoy, T. G. and Jacobs, A. (1986). DNA content and cell cycle analysis of bone marrow cells in myelodysplastic syndromes (MDS). Br. J. Haematol., 62, 239–245.
   PubMed Web of Science ®Google Scholar
• Raza, A., Mundle, S., Iftikhar, A., Gregory, S., Marcus, B., Khan, Z., Alvi, S., Shetty, V., Dameron, S. and Wright, V. (1995). Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am. J. Hematol., 48, 143–154.
   PubMed Web of Science ®Google Scholar
• Riccardi, A., Montecucco, C. M., Danova, M., Ucci, G., Mazzini, G., Giordano, P. A. and Pasquali, F. (1986). Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukemias. Basic Appl. Histochem., 30, 181–192.
   PubMedGoogle Scholar
• Wenthzel, A. M., Porwit, A., Lindahl, K., Widell, S. and Reizenstein, P. (1992). Bone marrow cells in the DNA-synthesis-phase in the myelodysplastic syndrome and lymphome. Med. Oncol. Tumor Pharmacother., 9, 51–55.
   PubMedGoogle Scholar
• Jensen, I. M., Hokland, M. and Hokland, P. (1993). A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry. Leuk. Res., 17, 839–846.
   PubMed Web of Science ®Google Scholar
• Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., Picard, F., Dreyfus, F. and Fontenay-Roupie, M. (1997). Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia, 11, 839–845.
   PubMed Web of Science ®Google Scholar
• Kitagawa, M., Kamiyama, R. and Kasuga, T. (1993). Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia. Hum. Pathol., 24, 359–363.
   PubMed Web of Science ®Google Scholar
• Thiele, J., Hoffmann, I., Bertsch, H. P. and Fischer, R. (1993). Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes. Virchows Archiv. A. Pathol. Anat., 423, 33–38.
   Google Scholar
• Pellegrini, W., Facchetti, F., Marocolo, D., Salvi, L., Capucci, A., Tironi, A. and Rossi, G. (1995). Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections. Histopathology, 27, 397–405.
   PubMed Web of Science ®Google Scholar
• Slymen, D. J., Miller, T. P., Lippman, S. M., Spier, C. M., Kerrigan, D. P., Rybaski, J. A., Rangel, C. S., Richter, L. C. and Grogan, T. M. (1990). Immunobiologic factors predictive of clinical outcome in diffuse large cell lymphoma. J. Clin. Oncol, 8, 986–993.
   PubMed Web of Science ®Google Scholar